Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209794294> ?p ?o ?g. }
- W3209794294 endingPage "101353" @default.
- W3209794294 startingPage "101353" @default.
- W3209794294 abstract "Within the superfamily of small GTPases, Ras appears to be the master regulator of such processes as cell cycle progression, cell division, and apoptosis. Several oncogenic Ras mutations at amino acid positions 12, 13, and 61 have been identified that lose their ability to hydrolyze GTP, giving rise to constitutive signaling and eventually development of cancer. While disruption of the Ras/effector interface is an attractive strategy for drug design to prevent this constitutive activity, inhibition of this interaction using small molecules is impractical due to the absence of a cavity to which such molecules could bind. However, proteins and especially natural Ras effectors that bind to the Ras/effector interface with high affinity could disrupt Ras/effector interactions and abolish procancer pathways initiated by Ras oncogene. Using a combination of computational design and in vitro evolution, we engineered high-affinity Ras-binding proteins starting from a natural Ras effector, RASSF5 (NORE1A), which is encoded by a tumor suppressor gene. Unlike previously reported Ras oncogene inhibitors, the proteins we designed not only inhibit Ras-regulated procancer pathways, but also stimulate anticancer pathways initiated by RASSF5. We show that upon introduction into A549 lung carcinoma cells, the engineered RASSF5 mutants decreased cell viability and mobility to a significantly greater extent than WT RASSF5. In addition, these mutant proteins induce cellular senescence by increasing acetylation and decreasing phosphorylation of p53. In conclusion, engineered RASSF5 variants provide an attractive therapeutic strategy able to oppose cancer development by means of inhibiting of procancer pathways and stimulating anticancer processes." @default.
- W3209794294 created "2021-11-08" @default.
- W3209794294 creator A5001348816 @default.
- W3209794294 creator A5002629528 @default.
- W3209794294 creator A5004000734 @default.
- W3209794294 creator A5027260604 @default.
- W3209794294 creator A5034212588 @default.
- W3209794294 creator A5072579760 @default.
- W3209794294 creator A5091214742 @default.
- W3209794294 date "2021-12-01" @default.
- W3209794294 modified "2023-10-16" @default.
- W3209794294 title "Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma" @default.
- W3209794294 cites W1513261706 @default.
- W3209794294 cites W1533028780 @default.
- W3209794294 cites W1585517331 @default.
- W3209794294 cites W1606858778 @default.
- W3209794294 cites W1849819493 @default.
- W3209794294 cites W1974140340 @default.
- W3209794294 cites W1987757198 @default.
- W3209794294 cites W1988409513 @default.
- W3209794294 cites W1989839956 @default.
- W3209794294 cites W1993735775 @default.
- W3209794294 cites W1995699249 @default.
- W3209794294 cites W2001400574 @default.
- W3209794294 cites W2007103582 @default.
- W3209794294 cites W2018295245 @default.
- W3209794294 cites W2019236201 @default.
- W3209794294 cites W2021830999 @default.
- W3209794294 cites W2022233074 @default.
- W3209794294 cites W2022448099 @default.
- W3209794294 cites W2024839004 @default.
- W3209794294 cites W2028519621 @default.
- W3209794294 cites W2028740022 @default.
- W3209794294 cites W2035293726 @default.
- W3209794294 cites W2049815423 @default.
- W3209794294 cites W2051710717 @default.
- W3209794294 cites W2054311839 @default.
- W3209794294 cites W2064086713 @default.
- W3209794294 cites W2073597741 @default.
- W3209794294 cites W2074552729 @default.
- W3209794294 cites W2074719974 @default.
- W3209794294 cites W2085497102 @default.
- W3209794294 cites W2093481978 @default.
- W3209794294 cites W2096942809 @default.
- W3209794294 cites W2099231523 @default.
- W3209794294 cites W2099540110 @default.
- W3209794294 cites W2128339707 @default.
- W3209794294 cites W2134354168 @default.
- W3209794294 cites W2143881980 @default.
- W3209794294 cites W2147046167 @default.
- W3209794294 cites W2152800355 @default.
- W3209794294 cites W2156571424 @default.
- W3209794294 cites W2159548367 @default.
- W3209794294 cites W2162607848 @default.
- W3209794294 cites W2165639753 @default.
- W3209794294 cites W2168249158 @default.
- W3209794294 cites W2269064503 @default.
- W3209794294 cites W2290420748 @default.
- W3209794294 cites W2330853815 @default.
- W3209794294 cites W2337260595 @default.
- W3209794294 cites W2339828620 @default.
- W3209794294 cites W2430419252 @default.
- W3209794294 cites W2464126598 @default.
- W3209794294 cites W2548573003 @default.
- W3209794294 cites W2554586955 @default.
- W3209794294 cites W2559900897 @default.
- W3209794294 cites W2583502740 @default.
- W3209794294 cites W2600997873 @default.
- W3209794294 cites W2608289720 @default.
- W3209794294 cites W2734751189 @default.
- W3209794294 cites W2735652142 @default.
- W3209794294 cites W2764265682 @default.
- W3209794294 cites W2764274701 @default.
- W3209794294 cites W2793544611 @default.
- W3209794294 cites W2947277814 @default.
- W3209794294 cites W2966295323 @default.
- W3209794294 cites W3008746166 @default.
- W3209794294 cites W3025364951 @default.
- W3209794294 cites W3092578600 @default.
- W3209794294 doi "https://doi.org/10.1016/j.jbc.2021.101353" @default.
- W3209794294 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8605244" @default.
- W3209794294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34717958" @default.
- W3209794294 hasPublicationYear "2021" @default.
- W3209794294 type Work @default.
- W3209794294 sameAs 3209794294 @default.
- W3209794294 citedByCount "2" @default.
- W3209794294 countsByYear W32097942942023 @default.
- W3209794294 crossrefType "journal-article" @default.
- W3209794294 hasAuthorship W3209794294A5001348816 @default.
- W3209794294 hasAuthorship W3209794294A5002629528 @default.
- W3209794294 hasAuthorship W3209794294A5004000734 @default.
- W3209794294 hasAuthorship W3209794294A5027260604 @default.
- W3209794294 hasAuthorship W3209794294A5034212588 @default.
- W3209794294 hasAuthorship W3209794294A5072579760 @default.
- W3209794294 hasAuthorship W3209794294A5091214742 @default.
- W3209794294 hasBestOaLocation W32097942941 @default.
- W3209794294 hasConcept C118716 @default.
- W3209794294 hasConcept C121608353 @default.